534-13-4
中文名稱
甘油雙硬脂酸酯
英文名稱
N,N'-DIMETHYLTHIOUREA
CAS
534-13-4
EINECS 編號(hào)
208-588-2
分子式
C3H8N2S
MDL 編號(hào)
MFCD00004923
分子量
104.17
MOL 文件
534-13-4.mol
更新日期
2024/12/20 09:28:14
534-13-4 結(jié)構(gòu)式
基本信息
中文別名
N,N-二甲基硫脲甘油雙硬脂酸酯
N,N'-二甲基硫脲
1,3-二甲基硫脲
對(duì)稱二甲硫脲
英文別名
1,3-DIMETHYL-2-THIOUREA1,3-DIMETHYLTHIOUREA
DIMETHYLTHIOCARBAMIDE
N,N'-DIMETHYLTHIOUREA
SYM-DIMETHYLTHIOUREA
(CH3NH)2CS
1,3-dimethyl-2-thio-ure
1,3-dimethylisothiourea
n,n’-dimethyl-thioure
thiourea,1,3-dimethyl-
Urea, 1,3-dimethyl-2-thio-
N,N'-Dimethylthiourea,98%
Thiourea, N,N-dimethyl-
dimethylsulfourea
N,N-DIMETHYLTHIOUREA(N,N'-DIMETHYLISOMER)
1,3-Dimethylthioureap
所屬類別
化學(xué)試劑：硫脲物理化學(xué)性質(zhì)
熔點(diǎn)61-63 °C
沸點(diǎn)155 °C (0.7501 mmHg)
密度1.055 (estimate)
折射率1.5500 (estimate)
閃點(diǎn)200 °C
儲(chǔ)存條件Store below +30°C.
溶解度1000g/l（實(shí)驗(yàn)）
酸度系數(shù)(pKa)14.98±0.70(Predicted)
形態(tài)晶體、結(jié)晶粉末和/或塊
顏色無(wú)色至白色
PH值6.5 (100g/l, H2O, 20℃)
Merck3261
BRN605454
InChIKeyVLCDUOXHFNUCKK-UHFFFAOYSA-N
CAS 數(shù)據(jù)庫(kù)534-13-4(CAS DataBase Reference)
NIST化學(xué)物質(zhì)信息Thiourea, N,N'-dimethyl-(534-13-4)
EPA化學(xué)物質(zhì)信息Thiourea, N,N'-dimethyl-(534-13-4)
安全數(shù)據(jù)
警示詞警告
危險(xiǎn)性描述H317
危險(xiǎn)品標(biāo)志T
危險(xiǎn)類別碼R25-R43
安全說(shuō)明S36/37-S45
危險(xiǎn)品運(yùn)輸編號(hào)UN 2811 6.1/PG 3
WGK Germany3
RTECS號(hào)YT1520000
F3-10
危險(xiǎn)等級(jí)6.1(b)
包裝類別III
海關(guān)編碼29309090
N,N'-二甲基硫脲價(jià)格(試劑級(jí))
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2024/11/11 | XW05341342 | 1,3-二甲基硫脲 n,n'-dimethylthiourea;1,3-dimethylthiourea;1,3-dimethyl-2-thiourea | 534-13-4 | 100G | 618元 |
| 2024/11/08 | D0804 | 1,3-二甲基硫脲 1,3-Dimethylthiourea | 534-13-4 | 5G | 135元 |
| 2024/11/08 | D0804 | 1,3-二甲基硫脲 1,3-Dimethylthiourea | 534-13-4 | 25G | 330元 |
常見(jiàn)問(wèn)題列表
生物活性
N,N'-Dimethylthiourea (DMTU) 是從黑蒜中分離出來(lái)的，是口服有效的羥基自由基 (?OH) 的清除劑，通過(guò)活化的中性粒細(xì)胞在體外阻止 ?OH 的產(chǎn)生。N,N'-Dimethylthiourea 通過(guò)發(fā)揮抗氧化作用，包括 ?OH 清除和抗炎作用，防止水浸限制應(yīng)激 (WIRS) 誘導(dǎo)的大鼠胃粘膜損傷。體內(nèi)研究
N,N'-Dimethylthiourea (DMTU; 1, 2.5, or 5 mmol/kg; orally) administered at 0.5 h before the onset of WIRS reduces the severity of gastric mucosal lesions with attenuation of the changes in the levels of gastric mucosal MPO, pro-inflammatory cytokines, LPO, NOx, nonprotein SH, and vitamin C and gastric adherent mucus found at 3 h after the onset of WIRS in a dose-dependent manner in Male Wistar rats aged 6 weeks.